Cognitive Resilience in Brain Health and Dementia Research
Authors:
- 8 November 2022
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 90 (2) , 461-473
Abstract
With the expected rise in Alzheimer’s disease and related dementias (ADRD) in the coming decades due to the aging population and a lack of effective disease-modifying treatments, there is a need for preventive strategies that may tap into resilience parameters. A wide array of resilience strategies has been proposed including genetics, socioeconomic status, lifestyle modifications, behavioral changes, and management of comorbid disease. These different strategies can be broadly classified as distinguishing between modifiable and non-modifiable risk factors, some of which can be quantified so that their clinical intervention can be effectively accomplished. A clear shift in research focus from dementia risk to addressing disease resistance and resilience is emerging that has provided new potential therapeutic targets. Here we review and summarize the latest investigations of resilience mechanisms and methods of quantifying resilience for clinical research. These approaches include identifying genetic variants that may help identify novel pathways (e.g., lipid metabolism, cellular trafficking, synaptic function, inflammation) for therapeutic treatments and biomarkers for use in a precision medicine-like regimen. In addition, innovative structural and molecular neuroimaging analyses may assist in detecting and quantifying pathological changes well before the onset of clinical symptoms setting up the possibility of primary and secondary prevention trials. Lastly, we summarize recent studies demonstrating the study of resilience in caregivers of persons living with dementia may have direct and indirect impact on the quality of care and patient outcomes.Keywords
This publication has 102 references indexed in Scilit:
- Prevalence of cerebrovascular lesions in patients with Lewy body dementia: A neuropathological studyClinical Neurology and Neurosurgery, 2013
- Plasma tau levels in Alzheimer's diseaseAlzheimer's Research & Therapy, 2013
- The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's diseaseFrontiers in Physiology, 2013
- Relation of neuropathology with cognitive decline among older persons without dementiaFrontiers in Aging Neuroscience, 2013
- Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease BrainsPLOS ONE, 2012
- Abca1 Deficiency Affects Alzheimer's Disease-Like Phenotype in Human ApoE4 But Not in ApoE3-Targeted Replacement MiceJournal of Neuroscience, 2012
- Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque PathologyArchives of Neurology, 2011
- The relationship between self‐efficacy and resting blood pressure in spousal Alzheimer's caregiversBritish Journal of Health Psychology, 2011
- Suppression of Aging in Mice by the Hormone KlothoScience, 2005
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996